Anti-ZNF2 monoclonal antibody

Pre-made anti-ZNF2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZNF2/ZNF2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2824-Ab-1/ GM-Tg-hg-IP2824-Ab-2Anti-Human ZNF2 monoclonal antibodyHuman
GM-Tg-rg-IP2824-Ab-1/ GM-Tg-rg-IP2824-Ab-2Anti-Rat ZNF2 monoclonal antibodyRat
GM-Tg-mg-IP2824-Ab-1/ GM-Tg-mg-IP2824-Ab-2Anti-Mouse ZNF2 monoclonal antibodyMouse
GM-Tg-cynog-IP2824-Ab-1/ GM-Tg-cynog-IP2824-Ab-2Anti-Cynomolgus/ Rhesus macaque ZNF2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2824-Ab-1/ GM-Tg-felg-IP2824-Ab-2Anti-Feline ZNF2 monoclonal antibodyFeline
GM-Tg-cang-IP2824-Ab-1/ GM-Tg-cang-IP2824-Ab-2Anti-Canine ZNF2 monoclonal antibodyCanine
GM-Tg-bovg-IP2824-Ab-1/ GM-Tg-bovg-IP2824-Ab-2Anti-Bovine ZNF2 monoclonal antibodyBovine
GM-Tg-equg-IP2824-Ab-1/ GM-Tg-equg-IP2824-Ab-2Anti-Equine ZNF2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2824-Ab-1/ GM-Tg-hg-IP2824-Ab-2; GM-Tg-rg-IP2824-Ab-1/ GM-Tg-rg-IP2824-Ab-2;
GM-Tg-mg-IP2824-Ab-1/ GM-Tg-mg-IP2824-Ab-2; GM-Tg-cynog-IP2824-Ab-1/ GM-Tg-cynog-IP2824-Ab-2;
GM-Tg-felg-IP2824-Ab-1/ GM-Tg-felg-IP2824-Ab-2; GM-Tg-cang-IP2824-Ab-1/ GM-Tg-cang-IP2824-Ab-2;
GM-Tg-bovg-IP2824-Ab-1/ GM-Tg-bovg-IP2824-Ab-2; GM-Tg-equg-IP2824-Ab-1/ GM-Tg-equg-IP2824-Ab-2
Products NameAnti-ZNF2 monoclonal antibody
Formatmab
Target NameZNF2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZNF2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2824-Ag-1Recombinant multi-species ZNF2/ A1-5/ ZNF661 protein


    Target information

    Target IDGM-IP2824
    Target NameZNF2
    Gene ID7549,72180,100909998,703864,123378917,539022,100062975
    Gene Symbol and Synonyms2810405K07Rik,A1-5,LOC100909998,Zfp661,ZNF2,ZNF661
    Uniprot AccessionQ9BSG1,Q29RZ4
    Uniprot Entry NameZNF2_HUMAN,ZNF2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000275111
    Target ClassificationN/A

    The target: ZNF2, gene name: ZNF2, also named as A1-5, ZNF661, Zfp661. The protein encoded by this gene belongs to the C2H2-type zinc-finger protein family. The exact function of this gene is not known, however, zinc-finger proteins are known to interact with DNA and function as transcription regulators. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.